Načítá se...
CSIG-20. INHIBITION OF AKT/SURVIVIN AND AKT/ID3 PATHWAYS BY CELECOXIB, A SELECTIVE COX-2 INHIBITOR, MAY HAVE PROMISING THERAPEUTIC POTENTIAL IN LOW-GRADE GLIOMA
Approximately half of the patients with low-grade glioma (LGG) treated surgically suffer recurrence or metastasis. Malignant transformation sometimes occurs after several years and no effective drug treatment has been established yet. Though the selective COX-2 inhibitor celecoxib showed anti-tumor...
Uloženo v:
Vydáno v: | Neuro Oncol |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Oxford University Press
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691934/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.214 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|